César de la Fuente is a Presidential Assistant Professor at the University of Pennsylvania, where he leads the Machine Biology Group. Previously, he pursued postdoctoral research at the Massachusetts Institute of Technology (MIT) and earned a PhD at the University of British Columbia (UBC). His research goal is to use the power of machines to accelerate discoveries in biology and medicine. Specifically, he pioneered the development of the first computer-designed antibiotic with efficacy in animal models, demonstrating the application of AI for antibiotic discovery and helping launch this emerging field. His lab has also been in the vanguard of developing computational methods for proteome mining, leading to the breakthrough discovery of a whole new world of antimicrobials. These efforts explored the human proteome as a source of antibiotics for the first time and have dramatically accelerated the time needed to discover preclinical candidates, from years to hours.